The plasminogen activator activity of arteries and veins in diabetes mellitus
- PMID: 1114482
- DOI: 10.1016/0049-3848(75)90022-5
The plasminogen activator activity of arteries and veins in diabetes mellitus
Similar articles
-
[Contact (prekallikrein) and fibrinolytic (plasminogen/antiplasmin value) system in the physiopathology of vascular complications of diabetes].J Mal Vasc. 1982;7(3):221-4. J Mal Vasc. 1982. PMID: 6815291 French.
-
Immunohistochemical localisation of tissue plasminogen activator and urokinase in the vessel wall.J Clin Pathol. 1985 Feb;38(2):140-5. doi: 10.1136/jcp.38.2.140. J Clin Pathol. 1985. PMID: 3881480 Free PMC article.
-
Markers of fibrinolysis may predict development of lower extremity arterial disease in patients with diabetes: A longitudinal prospective cohort study with 10 years of follow-up.Diab Vasc Dis Res. 2016 May;13(3):183-91. doi: 10.1177/1479164115618516. Epub 2016 Jan 27. Diab Vasc Dis Res. 2016. PMID: 26818227
-
Fibrinogen, fibrinolysis and diabetes mellitus: a comment.Diabetologia. 1997 Jun;40(6):738-40. doi: 10.1007/s001250050743. Diabetologia. 1997. PMID: 9222657 Review. No abstract available.
-
Mechanism on disorders of coagulation and fibrinolysis in diabetes.Diabetes. 1996 Jul;45 Suppl 3:S109-10. doi: 10.2337/diab.45.3.s109. Diabetes. 1996. PMID: 8674873 Review.
Cited by
-
Effect of PHA-B fraction of Agaricus bisporus lectin on insulin release and 45Ca2+ uptake by islets of Langerhans in vitro.Acta Diabetol Lat. 1984 Jan-Mar;21(1):63-70. doi: 10.1007/BF02624765. Acta Diabetol Lat. 1984. PMID: 6375227
-
Hypoglycemic treatments and the fibrinolytic system in maturity-onset diabetes mellitus without thromboembolic manifestations.Acta Diabetol Lat. 1983 Jan-Mar;20(1):63-70. doi: 10.1007/BF02629131. Acta Diabetol Lat. 1983. PMID: 6858544